Papua New Guinea Travel Health Guide: A Malaria Burden at a Decade High, a WHO Drug-Resistant TB Listing, and What Divers and Trekkers Should Know
Papua New Guinea carries a high malaria risk nationwide, and our clinical team prescribes atovaquone-proguanil for most travelers heading there. According to a June 2026 Asia Pacific Leaders Malaria Alliance (APLMA) analysis of the WHO World Malaria Report 2025, the country recorded 910,747 indigenous malaria cases in 2024, a decade high and a 162.9% increase since 2015, with an Annual Parasite Incidence of 102.5, the second-highest in the Asia-Pacific region. Papua New Guinea is also one of the World Health Organization's 2026 high-burden countries for tuberculosis and drug-resistant TB. The US State Department rates the country Level 3, Reconsider Travel, citing crime, civil unrest, and limited healthcare outside Port Moresby. Our clinical team recommends antimalarials, hepatitis A and typhoid vaccination, and a prepared medication kit well before departure. Start your visit on Wandr before you fly.
Papua New Guinea Travel Health Guide: A Malaria Burden at a Decade High, a WHO Drug-Resistant TB Listing, and What Divers and Trekkers Should Know
Papua New Guinea carries a high malaria risk nationwide, and our clinical team prescribes atovaquone-proguanil for most travelers heading there. According to a June 2026 Asia Pacific Leaders Malaria Alliance (APLMA) analysis of the WHO World Malaria Report 2025, the country recorded 910,747 indigenous malaria cases in 2024, a decade high and a 162.9% increase since 2015, with an Annual Parasite Incidence of 102.5, the second-highest in the Asia-Pacific region. Papua New Guinea is also one of the World Health Organization's 2026 high-burden countries for tuberculosis and drug-resistant TB. The US State Department rates the country Level 3, Reconsider Travel, citing crime, civil unrest, and limited healthcare outside Port Moresby. Our clinical team recommends antimalarials, hepatitis A and typhoid vaccination, and a prepared medication kit well before departure. Start your visit on Wandr before you fly.
By The Wandr Team Reviewed by Alec Freling, MD Last updated: October 17, 2026
Quick Facts: Papua New Guinea Health at a Glance
- Region: Melanesia, the eastern half of the island of New Guinea plus hundreds of smaller islands. Land area is about 452,860 square kilometers, with a mid-2026 population of roughly 10.9 million people. The capital is Port Moresby.
- Malaria Risk: High and present nationwide, including lowland and coastal areas. 2024 indigenous cases reached 910,747, a decade high, with an Annual Parasite Incidence of 102.5, second only to Solomon Islands in the Asia-Pacific region.
- Most-Affected Provinces: New Ireland, Madang, Morobe, Milne Bay, Sandaun, East Sepik, West New Britain, East New Britain, and Oro together account for 86% of the national malaria burden, according to APLMA's analysis of 2024 WHO data.
- Tuberculosis: Papua New Guinea is on the World Health Organization's 2026 list of high-burden countries for both tuberculosis and multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB).
- Yellow Fever: Not required for direct US travelers; a certificate is required only for travelers over one year old arriving from a yellow fever risk country.
- Recommended Vaccines: Hepatitis A, typhoid, and tetanus for most travelers; polio, hepatitis B, rabies, cholera, Japanese encephalitis, and TB screening considered depending on itinerary and length of stay.
- US Government Advisory: Level 3, Reconsider Travel, with Level 4, Do Not Travel, specifically for the Panguna mine area on Bougainville and most of the Highlands region outside Mount Hagen and Goroka.
- Altitude: Mount Wilhelm, the country's highest peak, reaches 4,509 meters; trekkers can feel altitude effects above 3,000 meters on the 2- to 3-day summit route.
- Travel Insurance Recommended: Yes, including medical evacuation coverage. Hospitals outside Port Moresby are often poorly equipped, medications can run short, and providers frequently expect payment up front.
Overview
Papua New Guinea occupies the eastern half of the island of New Guinea, the world's second-largest island, along with New Britain, New Ireland, Bougainville, Manus, and hundreds of smaller islands. It is one of the most linguistically diverse countries on Earth, home to rainforest trekking routes, the wreck- and reef-diving sites of Milne Bay, and the Kokoda Track, alongside a capital, Port Moresby, that most international flights route through via Brisbane, Cairns, or Singapore.
Our clinical team prepares Papua New Guinea-bound travelers around three realities that set it apart from many of the small, malaria-free Pacific nations we have covered in this series: malaria risk here is high and present essentially everywhere, including Port Moresby itself; 2026 WHO reporting classifies the country as high-burden for both ordinary and drug-resistant tuberculosis; and healthcare infrastructure outside the capital is thin enough that a well-stocked medication kit and evacuation-inclusive insurance matter more here than in most destinations. None of that should rule out a trip built around diving, trekking, or birdwatching. It does change what belongs in your pre-trip planning.
Malaria: A Decade-High Burden, Nationwide
Malaria is present throughout Papua New Guinea, including low-lying coastal areas and the islands, not just remote interior regions. Our clinical team prescribes atovaquone-proguanil (Malarone) for most Papua New Guinea itineraries, since chloroquine resistance is widespread in the region and doxycycline, while sometimes used clinically, is not part of Wandr's medication catalog.
The scale of the problem is well documented. A June 2026 analysis published by the Asia Pacific Leaders Malaria Alliance (APLMA), drawing on the WHO World Malaria Report 2025, found that Papua New Guinea recorded 910,747 indigenous malaria cases in 2024, a decade high and a 162.9% increase from 346,431 cases in 2015. The country's Annual Parasite Incidence reached 102.5 in 2024, the second-highest rate in the Asia-Pacific region after Solomon Islands, and the only two countries in the region above 100. Plasmodium falciparum cases, the species responsible for the most severe disease, rose 165.3% over the same period, climbing for three consecutive years after a roughly 40% jump in 2022.
There is a partial silver lining: malaria deaths fell for a second consecutive year, to 195 in 2024. Even so, Papua New Guinea accounted for nearly 60% of malaria deaths among the region's EDEN partner countries and 43% of malaria deaths across the entire Asia-Pacific region that year. APLMA's analysis attributes the broader resurgence since roughly 2013, after real progress between 2006 and 2013, to funding cuts, weaker vector control, commodity shortages, and reduced community health engagement. Nine provinces (New Ireland, Madang, Morobe, Milne Bay, Sandaun, East Sepik, West New Britain, East New Britain, and Oro) together account for 86% of the national burden, and most of them, including the Milne Bay dive region, are mainland lowland and coastal areas popular with travelers.
This section describes a decade-high national disease burden with a documented death toll; per our medical-sensitive content policy, it is flagged here for human clinical and factual review for tone and currency before this post leaves Draft status.
Our clinical team's practical guidance is straightforward: if your itinerary touches any part of Papua New Guinea, including Port Moresby, plan on taking an antimalarial for the duration of your trip, not just for a specific province. Start your visit on Wandr early enough to begin Malarone before departure; it typically requires only 1 to 2 days of lead time, which matters if your travel dates firm up late. For a deeper look at how antimalarials work and how to choose between them, see our complete guide to malaria prevention for travelers and our guide on how to get malaria pills online.
Tuberculosis: A WHO High-Burden Listing
Papua New Guinea appears on the World Health Organization's 2026 list of high-burden countries for both tuberculosis and multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB), a designation WHO maintains to direct global TB funding and surveillance toward the countries carrying the largest share of cases. This is a structural, longstanding classification rather than a single 2026 outbreak, and it is most relevant to travelers with prolonged stays, close contact with local communities, or healthcare-related volunteer work, rather than a short dive or trekking trip.
Our clinical team does not offer TB treatment or prophylaxis through Wandr; TB requires in-person diagnostic testing (typically a chest X-ray and sputum or blood testing) and, when active, a multi-month multidrug regimen managed by a specialist. If your trip involves extended time in Papua New Guinea, healthcare work, or close contact with local households, ask our clinical team about a baseline TB test before you go and again after you return, consistent with CDC guidance for travelers to high-burden countries.
Traveler's Diarrhea and Water Safety
Food and water safety follows the same precautions that apply across Melanesia and the wider Pacific. Treat all water as potentially contaminated: boil or otherwise sterilize water used for drinking, brushing teeth, or making ice. Milk is pasteurized and dairy products are generally considered safe. Eat only well-cooked meat and fish, cook vegetables thoroughly, and peel fruit yourself.
Our clinical team recommends carrying azithromycin as a first-line antibiotic for bacterial traveler's diarrhea, with ciprofloxacin as an alternative, plus dicyclomine for cramping and ondansetron for nausea. These medications are bundled into our Comprehensive Travel Package, built for itineraries where restocking at a pharmacy between remote lodges or dive liveaboards is not something to plan around.
Dengue, Japanese Encephalitis, and Mosquito-Bite Prevention Beyond Malaria
Dengue and Japanese encephalitis are both flagged as "to be considered" vaccines or precautions for Papua New Guinea by MASTA's travel health guidance, separate from the malaria risk addressed above. Neither has a Wandr-offered vaccine, so mosquito-bite prevention does double duty here: an EPA-registered repellent, long sleeves and pants where practical, and screened or air-conditioned sleeping arrangements where available protect against both malaria-carrying Anopheles mosquitoes and the Aedes and Culex mosquitoes that can carry dengue and Japanese encephalitis.
If you develop a high fever, severe headache, pain behind the eyes, or a rash within two weeks of visiting Papua New Guinea, seek medical evaluation and mention your travel history, since early recognition changes how dengue is managed. Avoid ibuprofen or other NSAIDs if dengue is suspected, since they can increase bleeding risk; ondansetron is the appropriate option for dengue-associated nausea instead. For a broader look at dengue prevention and symptoms, see our complete guide to dengue fever for travelers.
Vaccines and Routine Immunizations
Papua New Guinea is not a yellow fever risk country, so direct travelers from the United States do not need a yellow fever certificate. A certificate is required only for travelers over one year old arriving from a country with yellow fever risk, so check your full routing, not just your final stop, if you are connecting through Africa or South America.
MASTA's country-specific guidance recommends tetanus, hepatitis A, and typhoid fever vaccination for most travelers, and lists polio, hepatitis B, rabies, cholera, Japanese encephalitis, and TB screening as vaccines or precautions to consider depending on your itinerary, activities, and length of stay. World Travel Guide's health summary lists the same core set, with diphtheria and rabies noted as "sometimes" recommended. Our clinical team also confirms every traveler is current on routine vaccines like MMR before departure. Schedule your vaccine appointment through Wandr ahead of your trip so there is time for a multi-dose series if one applies to you.
Mount Wilhelm and Altitude: The Trek Most Guides Underplay
Mount Wilhelm, Papua New Guinea's highest peak at 4,509 meters, draws trekkers on a 2- to 3-day summit route that typically ends with a pre-dawn push to catch the sunrise from the top. According to the official Papua New Guinea tourism authority, altitude effects can appear above 3,000 meters, with headaches, tiredness, and nausea becoming more noticeable on the final approach to the summit; the guidance is to pace steadily and allow time to acclimatize.
If Mount Wilhelm, or any other high-altitude trek, is part of your itinerary, our clinical team can prescribe acetazolamide to help prevent altitude sickness. It is typically started the day before ascending and continued for a few days at altitude. This is a meaningfully different consideration than the flat coral atolls we have covered elsewhere in the Pacific, where altitude illness simply is not a factor.
Healthcare Infrastructure and Medical Evacuation
Healthcare access in Papua New Guinea is concentrated in Port Moresby and a handful of larger towns. Outside those centers, World Travel Guide's health summary notes that hospitals are often poorly equipped, medication shortages can occur, dental care is limited, and medical providers generally expect payment up front rather than billing insurance directly. Travelers who need ongoing treatment for a chronic condition are advised to confirm their medication supply covers the full trip, since restocking locally is not something to count on.
This is the practical reason travel health insurance, specifically insurance that explicitly covers medical evacuation, matters more in Papua New Guinea than in destinations with denser healthcare networks. Serious injuries, especially from diving incidents or remote trekking accidents, are typically evacuated to Port Moresby first and, for complex cases, onward to Australia. Explore travel insurance options through Wandr before you book, and confirm your policy explicitly names evacuation coverage rather than assuming standard trip insurance includes it.
The Safety Picture Beyond Health
The US State Department rates Papua New Guinea at Level 3, Reconsider Travel, citing crime (including armed robbery, carjacking, and kidnapping), civil unrest between communal and clan groups that can turn violent, and piracy in some coastal waters. The advisory separately rates the Panguna mine area on Bougainville and most of the Highlands region, outside Mount Hagen and Goroka, at Level 4, Do Not Travel, due to civil unrest. The country also sits on the Pacific Ring of Fire, with a standing risk of earthquakes, volcanic eruptions, and tsunamis that the advisory flags alongside the security concerns above.
None of this is primarily a health matter, but it shapes trip planning alongside it: travelers should stick to well-established tourism routes and operators, avoid the Highlands outside Mount Hagen and Goroka and the Bougainville mine area entirely, and register with the US Embassy's STEP program before departure. Our clinical team does not advise on visa, immigration, or security matters beyond general travel health guidance; for current, authoritative information on either, consult travel.state.gov directly.
Getting There and Getting Around: Motion Sickness and Travel Fatigue
Most US travelers reach Papua New Guinea via Brisbane, Cairns, Singapore, or Port Moresby's limited direct connections, often followed by a smaller regional flight to a provincial airstrip, since road connections between many regions are limited or nonexistent. Inter-island travel for diving itineraries frequently means a liveaboard boat transfer, which can be considerably rougher than the long-haul leg that got you to the Pacific in the first place.
Meclizine and the scopolamine patch both work well for shorter, bumpier regional flights and boat transfers, and hydroxyzine is a reasonable option for the anxiety and disrupted sleep that can come with a long, multi-leg itinerary and limited rebooking options if a connection changes. Our Comprehensive Travel Package bundles these with the traveler's diarrhea medications above into one pre-trip order.
Practical Prep Timeline
- 6-8 weeks out: Begin hepatitis A vaccination (ideally at least two weeks before departure), ask our clinical team whether a baseline TB test fits your itinerary, and confirm whether polio, hepatitis B, or Japanese encephalitis vaccination makes sense for your specific plans.
- 1-2 weeks out: Start your antimalarial on the schedule our clinical team sets, pack an EPA-registered mosquito repellent, and confirm your travel insurance explicitly covers medical evacuation, including dive-injury and remote-trek evacuation if either is on your itinerary.
- Before you fly: Pack your full medication kit rather than planning to restock locally, confirm your regional flight and liveaboard connection timing well in advance, and if Mount Wilhelm or another high-altitude trek is planned, confirm your acetazolamide supply and acclimatization schedule.
Medical Disclaimer
This guide is for general educational purposes and does not replace individualized medical advice. Health risks, vaccine guidance, and travel advisories change, and our clinical team reviews your specific itinerary, health history, and travel dates before prescribing anything. Entry and immigration requirements are set by the Papua New Guinea government and the US Department of State; confirm current requirements directly with Papua New Guinea's government or travel.state.gov before you travel, since this guide does not make visa or immigration determinations.
Frequently Asked Questions
Do I need malaria pills for Papua New Guinea? Yes. Malaria risk is high and present nationwide, including coastal and lowland areas. Our clinical team prescribes atovaquone-proguanil (Malarone) for most Papua New Guinea itineraries.
How bad is the malaria situation in Papua New Guinea right now? Significant. A June 2026 APLMA analysis of WHO data found 910,747 indigenous cases in 2024, a decade high and a 162.9% increase since 2015, with an Annual Parasite Incidence of 102.5, the second-highest in the Asia-Pacific region.
Is Papua New Guinea a high-risk country for tuberculosis? Yes. It is on the World Health Organization's 2026 list of high-burden countries for both tuberculosis and multidrug-resistant/rifampicin-resistant TB. This mainly matters for extended stays or close community contact rather than a short trip.
Do I need a yellow fever vaccine for Papua New Guinea? No, not for direct travel from the United States. A certificate is required only if you arrive within the risk window from a yellow fever risk country.
What vaccines should I get before traveling to Papua New Guinea? Hepatitis A, typhoid, and tetanus are recommended for most travelers, with polio, hepatitis B, rabies, cholera, Japanese encephalitis, and TB screening considered depending on your itinerary and length of stay.
Is it safe to visit Papua New Guinea right now? The US State Department rates Papua New Guinea at Level 3, Reconsider Travel, due to crime, civil unrest, and piracy, with Level 4, Do Not Travel, for the Bougainville mine area and most of the Highlands outside Mount Hagen and Goroka.
Do I need altitude sickness medication for Papua New Guinea? Only if your itinerary includes a high-altitude trek like Mount Wilhelm, which reaches 4,509 meters. Altitude effects can appear above 3,000 meters, and our clinical team can prescribe acetazolamide for that specific itinerary.
What is the healthcare system like in Papua New Guinea? Concentrated in Port Moresby and a handful of larger towns. Hospitals elsewhere are often poorly equipped, medication shortages can occur, and providers typically expect payment up front, which is why evacuation-inclusive travel insurance matters here.
How far in advance should I prepare for a Papua New Guinea trip? Start 6 to 8 weeks out for vaccines, and finalize your antimalarial schedule, mosquito repellent, and evacuation-inclusive travel insurance 1 to 2 weeks before departure.
Sources
- Asia Pacific Leaders Malaria Alliance (APLMA). "Malaria in Papua New Guinea: Current Landscape and a Strengthened Push Towards Elimination," June 26, 2026, citing the WHO World Malaria Report 2025 (indigenous case counts, Annual Parasite Incidence, death toll, most-affected provinces). https://www.aplma.org/blog/malaria-in-papua-new-guinea-current-landscape-and-a-strengthened-push-towards-elimination
- World Health Organization, via West Virginia Department of Health. High Burden Countries for TB, 2026 list (Papua New Guinea's inclusion for TB and MDR/RR-TB). https://oeps.wv.gov/tuberculosis/Documents/community/High_Burden_Countries_for_TB_2026.pdf
- Overseas Security Advisory Council (OSAC), US Department of State. Papua New Guinea country security report (Level 3 advisory, Level 4 sub-national areas, crime, civil unrest, healthcare, natural hazards). https://www.osac.gov/Country/PapuaNewGuinea/Content/Detail/Report/0e63d73f-4407-4f5a-aae0-27178ea44db3
- MASTA. Papua New Guinea travel health guidance (malaria status, recommended and considered vaccines). https://masta.com/continent/australasia-pacific/papua-new-guinea/
- World Travel Guide. Papua New Guinea health information (vaccines, water safety, healthcare access, medical evacuation). https://www.worldtravelguide.net/guides/oceania/papua-new-guinea/health
- Worldometer. Papua New Guinea population and land area, mid-2026 estimate. https://www.worldometers.info/world-population/papua-new-guinea-population/
- Papua New Guinea Tourism Promotion Authority. "Mount Wilhelm: Papua New Guinea's Highest Peak" (elevation, altitude effects, trek duration). https://papuanewguinea.travel/natural-landmarks/mount-wilhelm-png/
- CDC Yellow Book. Travelers' Diarrhea chapter (general attack-rate and prevention guidance). https://www.cdc.gov/yellow-book/hcp/preparing-international-travelers/travelers-diarrhea.html
Note for reviewer: this run departed from the recent Pacific sub-series' zero-malaria small-island pattern (Vanuatu, Samoa, Tonga, Palau, Solomon Islands, Kiribati, Nauru, Marshall Islands, Tuvalu, Federated States of Micronesia), since that shortlist of zero-coverage small Pacific nations is now fully exhausted as of the 2026-10-16 (FSM) run. Per the TOPIC SELECTION WEIGHTING section of _content-calendar.md, the NEW TOPICS table's Idea-status backlog has been empty since 2026-09-09, so this run generated a new topic per the skill's new-topic rules rather than selecting from the (empty) backlog. Re-verified via fresh Drive title searches across content-pipeline/drafts/, content-pipeline/published/, and content-pipeline/rejected/ that zero dedicated destination-guide posts exist for Papua New Guinea (also checked and ruled out Jamaica, Bahamas, Barbados, Belize, Panama, Honduras, Guatemala, Fiji, Laos, Myanmar, Mongolia, Namibia, Zambia, Uganda, Oman, Iceland, Greece, Croatia, Georgia, Bolivia, Argentina, Chile, Taiwan, Malaysia, New Zealand, Australia, Saudi Arabia, Canada, South Korea, Singapore, Guinea, Finland, Belgium, Denmark, Switzerland, Netherlands, Ireland, Norway, and UAE, all of which already have a confirmed post in published/). Myanmar (Burma, Level 4 Do Not Travel per a live travel.state.gov fetch), Lebanon (Level 4 per search corroboration), Qatar and Oman (both freshly Level 3 as of a live OSAC/travel.state.gov fetch, due to the US-Iran hostilities that began February 28, 2026) were considered and passed over: Qatar and Oman for an active regional armed-conflict risk that changed materially and recently, and Venezuela (Level 3, but primarily for crime, kidnapping, and a June 2026 earthquake rather than a travel-health story, with several interior states at Do Not Travel) was also passed over as a weaker fit for a travel-health-led post. Papua New Guinea was selected because it clears the citation and statistics bar with a live, dated, WHO-sourced malaria statistic set (a decade-high national case count, confirmed via a live WebFetch of APLMA's June 2026 blog post, which itself cites the WHO World Malaria Report 2025) and a live-confirmed 2026 WHO high-burden TB/MDR-TB listing, both of which are a genuine departure from the zero-malaria angle used repeatedly in the recent small-island Pacific run. Its Level 3 advisory is corroborated across three independently fetched or searched sources (OSAC, travelwarningcheck.com, and a 2018-dated secondary source flagged in-body as such and not relied on for current figures) and is driven primarily by crime and civil unrest rather than an active armed conflict, which this run judged an acceptable risk profile for a travel-health-led post, consistent with prior-run precedent covering Level 2-3 countries such as Sierra Leone, Liberia, Guinea, and Angola. Live WebFetch attempts against CDC's own malaria country-table page (cdc.gov) and travel.state.gov's Papua New Guinea page both returned PROVENANCE_REQUIRED errors in this unattended session (no one available to approve), consistent with the access-wall pattern noted in every run log since late September, so MASTA and World Travel Guide were used as corroborating secondary sources for vaccine and malaria-status guidance, and OSAC plus a search-engine-corroborated secondary source were used for the advisory level, consistent with precedent from prior runs when primary government fetches are blocked. Pillar 6 weighting check: the last 8 drafted/published posts (Palau, Solomon Islands, Kiribati, Nauru, Marshall Islands, Tuvalu, Federated States of Micronesia, and this post's own predecessor slot) include 0 Travel Planning posts, so there is no cap conflict, and this remains a Tier 2 Destination Health Hub topic rather than Pillar 6. Catalog-fit gate passed via direct fits: atovaquone-proguanil is a direct fit for the high, nationwide malaria risk (the central angle of this post); azithromycin/ciprofloxacin/dicyclomine/ondansetron are a direct fit for traveler's diarrhea and dengue-associated nausea; meclizine/scopolamine/hydroxyzine are a direct fit for regional-flight and liveaboard-boat motion sickness and travel anxiety; acetazolamide is a direct fit for the Mount Wilhelm high-altitude trekking angle, a genuine point of difference from the flat-atoll posts earlier in this series. Tuberculosis is discussed as a risk-awareness and screening-recommendation item only, deliberately without naming any Wandr medication as TB treatment, since TB treatment is outside Wandr's catalog and scope; this avoids overclaiming catalog fit where it would not be honest, consistent with the Nauru run's handling of rabies and the FSM run's handling of leptospirosis. No "delivered to your door" framing used anywhere in the post; CTAs used "start your visit," "schedule your vaccine appointment," and "explore travel insurance options" instead. No visa or immigration determination given; the medical disclaimer and the Safety Picture section both direct readers to travel.state.gov and the PNG government for current entry and security guidance rather than this post making that determination. Deliberately omitted the HIV/STI prevalence commentary and medical-visa-documentation requirement mentioned in World Travel Guide's source page: it is about the resident population and immigration medical screening rather than a short-stay traveler's trip-prep needs, so including it would have added a stigmatizing, out-of-scope tangent without a clear reader benefit, consistent with the Nauru run's precedent for excluding a similarly tangential statistic. Author rotation: the last three confirmed posts were Marshall Islands (2026-10-14, The Wandr Team, with Alec Freling, MD as medical_reviewer), Tuvalu (2026-10-15, Alec Freling, MD, with Mark Karam, PA-C as medical_reviewer), and Federated States of Micronesia (2026-10-16, Mark Karam, PA-C, with Alec Freling, MD as medical_reviewer); continuing the Team -> MD -> PA-C cycle lands on The Wandr Team for this post, with Alec Freling, MD added as medical_reviewer, matching the exact field values used for the Marshall Islands post's Team byline. Author bio, credentials, and role copied verbatim from the Marshall Islands post's precedent and _agent-instructions.md Section 5b; no credentials or claims added beyond the approved strings. 0 em-dashes and 0 smart quotes used in this draft (checked by visual review of the full text); straight ASCII quotes only. YAML front matter structured to match the exact schema and field order used by the three immediately preceding posts (Nauru, Tuvalu, FSM); a human reviewer should still run yaml.safe_load on this file before it leaves Draft status, since this run did not have Python/shell access to validate it programmatically before saving to Drive. Approximately 2,250 body words excluding sources and frontmatter (within the T2 destination-guide 2,000-3,000 word range), 9-question FAQ, 8 numbered sources (exceeding the 2+ CDC/WHO/peer-reviewed-equivalent minimum via the WHO-sourced APLMA malaria analysis and the WHO TB high-burden list specifically) and well over the 3+ statistic minimum (malaria case counts, API, death toll, population, land area, advisory level, Mount Wilhelm elevation, among others). Given the "medical-sensitive content always needs human review" guardrail, the Malaria section (a decade-high national burden with a documented death toll) is flagged in its own in-body reviewer note for human clinical and factual review before this post leaves Draft status. Featured image NOT selected this run: a live WebFetch attempt against Unsplash's search page for "papua-new-guinea" returned a PROVENANCE_REQUIRED error (no one available to approve in this unattended session), consistent with the access-wall pattern noted in every run log since late September. Rather than invent an unverified photo ID, this draft ships with query-only image fields (no url) and an image_status: NEEDS VERIFICATION flag; nothing was appended to _image-registry.md or featured-images-log.md this run since no real photo ID was chosen, and the curated image pool in _image-registry.md was checked (via keyword search for "papua," "pacific islands," "coral reef," "diving," "melanesia," and "jungle") and found to contain no close match for Papua New Guinea-specific imagery. Internal links checked against _approved-internal-links.md (/destination-check, /features/vaccines, /features/insurance, /medication/atovaquone-proguanil, /medication/azithromycin, /medication/ciprofloxacin, /medication/ondansetron, /medication/meclizine, /medication/scopolamine, /medication/hydroxyzine, /medication/acetazolamide, /medication/comprehensive-kit); dicyclomine is named in body text only, not hyperlinked, since it is not in the confirmed medication-slug list, consistent with prior-run precedent. Blog cross-links (malaria-prevention-travelers-complete-guide, how-to-get-malaria-pills-online, dengue-fever-travelers-prevention-symptoms-treatment) were freshly verified this run via Drive title search against content-pipeline/published/, confirming all three are live posts rather than reused unchecked from a prior run's list. Saved to content-pipeline/drafts/2026-10-travel-health-guide-papua-new-guinea.md.
Related Wandr Content
- Malaria Prevention for Travelers: The Complete Guide
- How to Get Malaria Pills Online Without a Travel Clinic Visit
- Dengue Fever in Travelers: A Physician's Complete Guide to Prevention, Symptoms & Treatment
Our clinical team reviews every Papua New Guinea itinerary before prescribing, from malaria prevention to altitude sickness coverage. Start your visit on Wandr, browse the full medication catalog, or explore vaccine appointment booking and travel insurance options before you fly.
The Wandr Team is the editorial group at Wandr Health; every article is reviewed by a licensed clinician before publication.